What is it?
MiGRACAPS® capsules contain Tanacetum parthenium (otherwise known as Feverfew).
MiGRACAPS® may reduce the frequency of migraines.
Feverfew has been traditionally used in herbal medicine to assist in the management of fever and headaches. It may also assist with pain associated with inflammatory conditions such as arthritis.
MiGRACAPS® –natural and effective
What is Feverfew?
Feverfew has been used for centuries as a relaxant
to help lower the frequency and calm the severity of
symptoms associated with migraine headaches. Today,
Feverfew is most often taken as a preventative
measure against the onset of migraine and many other
inflammatory conditions.
Many studies have found Feverfew administration to
result in a reduction in the severity of symptoms
associated with migraine, as compared to placebo.
The mode of action of Feverfew may involve the
inhibition of platelet aggregation and prostaglandin
synthesis. Feverfew has anti-inflammatory and
vasodilatory properties that may work to reduce
blood vessel spasms and inhibit the release of
inflammatory substances. Feverfew may benefit many
conditions involving inflammation.
Feverfew is suitable to take in the long term to
help minimise the frequency of migraine attack and,
in the short term, to help ease the severity of
symptoms. Feverfew can be taken for many
inflammatory conditions ranging from inflammatory
skin conditions to inflammation of body joints.
Mode of Action
• Inhibits serotonin release from platelets
• Inhibits platelet aggregation
• Reduces blood vessel constriction
• Inhibits formation and release of inflammatory
substances
Migraine is the result of an inflammatory phenomenon
which occurs in the blood vessels surrounding the
brain. Platelets in migraine sufferers have been
demonstrated to aggregate (clump) more readily than
in others. This occurs both spontaneously and when
exposed to serotonin and catecholamines such as
adrenaline.
If the blood levels of catecholamines rise,
serotonin, which is a potent vasoconstrictor, is
released. This causes platelet aggregation and
vasospasm (spasm of blood vessels) which then leads
to an interruption of blood flow to the brain. This
is then followed by a 'rebound' vasodilation
(widening of the blood vessels) and the release of
pain inducing substances. This sequence of events
leads to the characteristic symptoms associated with
a migraine headache.
Sesquiterpene lactones, particularly parthenolide,
are thought to be the main active constituents of
Feverfew. They inhibit platelet aggregation and the
secretion of serotonin which can trigger the
vasoconstriction leading to a migraine.
What is in it?
Each capsule contains Tanacetum parthenium powder
equivalent to 520mg dry flowering herb top.
Precautions, Contraindications and Side Effects
Use only as directed. If symptoms persist see your healthcare professional. Not to be used in children under two years of age without medical advice.
MiGRACAPS® is Gluten-free and contains no artificial flavourings or colours. It is also suitable for vegetarians.
Directions for Use
Take one capsule twice a day for the first 4 weeks.
After the first four weeks the dosage may be reduced
to one capsule once a day.
The beneficial effects of MiGRACAPS® may take 2-4
weeks to occur.
Additional benefit may be obtained by using
Migrastick® to assist with rapid relief of migraine
at the first sign of a migraine headache.
Pack
Size
90 Capsules
Where to get it
Arkopharma Australia products are available through
pharmacies, and healthfood stores.
Please click on either
supermarkets or pharmacies to download a PDF for all
available locations within Australian states.
::
Supermarkets (500kb)
::
Pharmacies (491kb)
|
